Control immune function with engineered neural signals
Engineered electrical signals, delivered by earbuds, help the brain regain control of immune
function by modulating neurological pathways.
Engineered electrical signals, delivered by
earbuds, help the brain regain control of immune
function by modulating neurological pathways.
Team
Nēsos was founded by Konstantinos Alataris, PhD and a team of neuroscientists and engineers that have developed disease modifying digital therapeutics for neurological disorders. As the founder and former CEO of Nevro (NYSE: NVRO), Konstantinos steered product development and brought to market Senza, Nevro's market-leading, implantable neuromodulation therapy for the treatment of chronic pain.
Nēsos is critically supported by expert clinical and scientific collaborators from leading academic institutions, including Stanford, Vall d'Hebron, Harvard, Mount Sinai, Feinstein Institute, University Of California, San Diego (UCSD), and the University Of California, San Francisco (UCSF).
Board
- Sunil Agarwal, MD Sana Biotechnology, Juno, Genentech
- Mark Genovese, MD Gilead, Stanford
- Andre Walker Nevro, Abbott
- Ursheet Parikh Mayfield Fund
- Konstantinos Alataris, PhD. Nevro, Boston Scientific
PUBLICATIONS
EULAR 2020 Poster
ACR 2020 Oral presentation by Matt Baker MD (Stanford)
Press
Connect
Nēsos aims to treat diseases, by restoring neurological pathways that control immune function. Using engineered electrical signals delivered by a noninvasive brain interface. Nēsos is guided and supported by clinical and scientific collaborators from top academic institutions, including Stanford, Vall d'Hebron, Harvard, Mount Sinai, Feinstein Institute, University of California, San Diego, and University of California, San Francisco. For more information, visit www.nesos.com.
© 2021 Nēsos Corp, All Rights Reserved